Category: Patient Care + Research + Clinical Trials

At long last, we’ve put together the BC Diabetes Loop (Artificial Pancreas) Study and we’re pleased to share the results and analysis. Over the last 2 years, BC Diabetes has been leading the pack when it comes to using technology in the treatment of diabetes.  Our Medical Director, Dr. Tom Elliott, is an early adopter, […]

The Artificial Pancreas (automated insulin delivery, AID) is here and we are not waiting! On 2020-Aug-1 BCDiabetes began doing in-house installations of the Omnipod Eros/Dash-Dexcom G6/G7-Riley link Loop system (Dash does not require Riley link).  Although this system is not Health Canada approved, it is our default recommendation.  This is because it is a mature […]

A message from Dr. Elliott: Nobody would ever choose to have diabetes, but if you had to choose the best place in the world to live with Type 1 diabetes you might well choose British Columbia.  So wrote Dr. Ben Mammon in an email to me late Friday night, the same day BC’s Minister of […]

A Message From Dr. Elliott: I’m writing to share the momentous news that earlier today BC Pharmacare announced coverage of continuous glucose monitors, otherwise known as CGM. BC will thus join the Yukon territory, Quebec and Saskatchewan.  I trust that the other provinces & territories will quickly follow suit so that all Canadians can benefit […]

Artificial Pancreas Systems (APS, also termed “automated insulin delivery” AID systems) are here and we are not waiting! On 2020-Aug-1 BCDiabetes began supporting in-house installations of DIYAPS with the tubeless Omnipod Eros-Dexcom G6-Riley link-iPhone master branch “Loop” system. Although not Health Canada approved, BCDiabetes considers this version of Loop to be the best DIY APS […]

Dr. Elliott and the entire staff at BC Diabetes are delighted to report that COVID-19 vaccines are being made available to all British Columbians who are taking insulin. On Tuesday, March 23rd, 2021, the Government of British Columbia put out a statement saying that people who were “clinically extremely vulnerable” were now eligible to receive […]

In 2018 with the arrival in Canada of continuous glucose monitors (CGM) a diabetes revolution began.  CGM meant no more finger pricking, no fear of going low overnight; vastly improved glucose control and a future without the dreaded long-term complications of diabetes. The revolution continued in early 2020 with the artificial pancreas being made possible […]

Continuous Glucose Monitoring, known as CGM, allows for the automatic tracking of glucose (sugar) levels for people living with Type 1 Diabetes (TID).  Keeping sugar levels within a safe & healthy target range (5-10 mmol/L) is crucial to prevent the dreaded diabetes complications of loss of consciousness, heart disease & stroke, blindness, kidney failure and […]